Evidence map›Paper›PMID 27743014›Full record

ReviewThe Journal of membrane biology2017

Membrane Protein Quantity Control at the Endoplasmic Reticulum.

Ignat Printsev, Daniel Curiel, Kermit L Carraway

Abstract readReview
In one paragraph

Review in The Journal of membrane biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons.Journal of experimental & clinical cancer research : CR · 2021
    Review
  15. Article
  16. Article
  17. Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In Vivo.Molecular therapy : the journal of the American Society of Gene Therapy · 2020
    Article
  18. Review
  19. Effect of Praziquantel onPathogens (Basel, Switzerland) · 2020
    Article
  20. Supramolecular clustering of the cardiac sodium channel Nav1.5 in HEK293F cells, with and without the auxiliary β3-subunit.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ignat PrintsevDepartment of Biochemistry and Molecular Medicine, and UC Davis Comprehensive Cancer Center, UC Davis School of Medicine, Research Building III, Room 1100B, 4645 2nd Avenue, Sacramento, CA, 95817, USA.
Daniel CurielDepartment of Biochemistry and Molecular Medicine, and UC Davis Comprehensive Cancer Center, UC Davis School of Medicine, Research Building III, Room 1100B, 4645 2nd Avenue, Sacramento, CA, 95817, USA.
Kermit L CarrawayDepartment of Biochemistry and Molecular Medicine, and UC Davis Comprehensive Cancer Center, UC Davis School of Medicine, Research Building III, Room 1100B, 4645 2nd Avenue, Sacramento, CA, 95817, USA. klcarraway@ucdavis.edu.

Funding

NRDP1 PROTEIN DEGRADATION PATHWAY IN MAMMARY TUMOR PROGRESSIONR01CA123541 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARRAWAY, KERMIT L · 2006 to 2016
$2.5M
Muc4 Involvement in Mammary Tumor ProgressionR01CA166412 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARRAWAY, KERMIT L · 2013 to 2017
$1.5M
Novel method of identifying circulating mammary tumor cellsR21CA178681 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARRAWAY, KERMIT L · 2013 to 2014
$362k
Negative regulation by proteasomal degradation of receptor tyrosine kinase ErbB3F31CA165546 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI PRINTSEV, IGNAT · 2012 to 2015
$143k
National Cancer Institute CA123541National Cancer Institute CA165546National Cancer Institute CA166412National Cancer Institute CA178681NCI NIH HHS F31 CA165546NCI NIH HHS R01 CA123541NCI NIH HHS R01 CA166412NCI NIH HHS R21 CA178681
6 · The paper itself

Abstract

The canonical function of the endoplasmic reticulum-associated degradation (ERAD) system is to enforce quality control among membrane-associated proteins by targeting misfolded secreted, intra-organellar, and intramembrane proteins for degradation. However, increasing evidence suggests that ERAD additionally functions in maintaining appropriate levels of a subset of membrane-associated proteins. In this 'quantity control' capacity, ERAD responds to environmental cues to regulate the proteasomal degradation of specific ERAD substrates according to cellular need. In this review, we discuss in detail seven proteins that are targeted by the ERAD quantity control system. Not surprisingly, ERAD-mediated protein degradation is a key regulatory feature of a variety of ER-resident proteins, including HMG-CoA reductase, cytochrome P450 3A4, IP

Indexed as

Endoplasmic Reticulum-Associated DegradationAnimalsCaenorhabditis elegansEndoplasmic ReticulumEukaryotic CellsHumansHydroxymethylglutaryl CoA ReductasesInositol 1,4,5-Trisphosphate ReceptorsIodide PeroxidaseIodothyronine Deiodinase Type IIProteasome Endopeptidase ComplexProteolysisReceptor, ErbB-3Saccharomyces cerevisiaeSignal TransductionUbiquitinationERBB3 protein, humanHydroxymethylglutaryl CoA ReductasesInositol 1,4,5-Trisphosphate ReceptorsIodide PeroxidaseIodothyronine Deiodinase Type IIProteasome Endopeptidase ComplexReceptor, ErbB-3RNF41 protein, humanUbiquitin-Protein LigasesEndoplasmic reticulumERAD pathwayProtein degradationQuality controlUbiquitination

Identifiers

PMID27743014
PMCPMC5392169

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.